0000919574-20-002265.txt : 20200310
0000919574-20-002265.hdr.sgml : 20200310
20200310171039
ACCESSION NUMBER: 0000919574-20-002265
CONFORMED SUBMISSION TYPE: 13F-HR/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20200310
DATE AS OF CHANGE: 20200310
EFFECTIVENESS DATE: 20200310
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kite Lake Capital Management (UK) LLP
CENTRAL INDEX KEY: 0001687444
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18700
FILM NUMBER: 20702874
BUSINESS ADDRESS:
STREET 1: 1 KNIGHTSBRIDGE GREEN
STREET 2: 6TH FLOOR
CITY: LONDON
STATE: X0
ZIP: SW1X 7QA
BUSINESS PHONE: 44 20 7052 8311
MAIL ADDRESS:
STREET 1: 1 KNIGHTSBRIDGE GREEN
STREET 2: 6TH FLOOR
CITY: LONDON
STATE: X0
ZIP: SW1X 7QA
13F-HR/A
1
primary_doc.xml
13F-HR/A
LIVE
false
true
false
0001687444
XXXXXXXX
12-31-2019
12-31-2019
true
1
RESTATEMENT
false
Kite Lake Capital Management (UK) LLP
1 Knightsbridge Green
6th Floor
London
X0
SW1X 7QA
13F HOLDINGS REPORT
028-18700
Y
This filing seeks to correct the Form 13F filed on February 14, 2020, by removing two lines of information under the issuer "SPDR S&P 500 ETF TR" as the positions listed were not held by the institutional investment manager as of December 31, 2019.
Rupert Haworth-Booth
Chief Operating Officer
44-20-7052-8311
/s/ Rupert Haworth-Booth
London
X0
03-10-2020
1
5
31565
1
0001734681
028-18701
KL Special Opportunities Master Fund Ltd.
INFORMATION TABLE
2
infotable.xml
BRISTOL MYERS SQUIBB CO
RIGHT 99/99/9999
110122157
1331
442340
SH
DFND
442340
0
0
CHINA BIOLOGIC PRODS HLDGS I
COM
G21515104
15309
131540
SH
DFND
131540
0
0
CHINA BIOLOGIC PRODS HLDGS I
COM
G21515104
8826
75842
SH
SOLE
75842
0
0
QIAGEN NV
SHS NEW
N72482123
3912
115753
SH
DFND
115753
0
0
QIAGEN NV
SHS NEW
N72482123
2187
64702
SH
SOLE
64702
0
0